Health Care: Drugs

Oncothyreon Inc (ONTY: NASDAQ)

$2.09 n/a | n/a%
09/19/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.09
52 Week High 4.08
52 Week Low 1.67
Avg. Daily Vol. (Mil) 0.80
Beta (3 year) 1.57
Share Related Items
Mkt Cap (Mil) 147.99
Shares Out (Mil) 70.81
Float (Mil) 61.45
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 13.60
Current Ratio 13.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 2.58
Price/Cash Flow -5.20
Per Share Data
Earnings -0.42
Sales 0.00
Book Value 0.81
Cash Flow -0.40
Business Summary
Oncothyreon Inc is a clinical-stage biopharmaceutical company. It develops and commercialize synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients.
General Information
2601 Fourth Avenue
Suite 500
Seattle, WA 98121
www.oncothyreon.com
Industry : Drugs
Sector: Health Care
Employees: 43
CEO: Dr. Robert L. Kirkman, M
Short Interest
Current Month (Mil) 5.17
Previous Month (Mil) 5.44
Short Interest Ratio (Days) 9.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -46.80
Return on Investments -51.90
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ONTY

Latest ONTY Headlines from TheStreet

More Financial News for ONTY

Press Releases for ONTY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter